Carotenoids and eye disease: Epidemiological evidence

Carotenoids in Health and Disease

Volumn , Issue , 2004, Pages 427-444

  Mares, Julie A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646144735     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Landrum JT, Bone RA. Mechanistic evidence for eye diseases and carotenoids. In this volume.
2. Klein R, Klein BEK, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999; 106(6): 1056-1065.
3. Klein R, Klein BEK, Tomany SC, Meure SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2002; 109(10): 1767-1779.
4. National Society to Prevent Blindness Vision Problems in the US: Data Analyses. New York: National Society to Prevent Blindness, 1980: 1-46.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119(10): 1417-1436.
6. Mares-Perlman JA, Klein R. Diet and age-related macular degeneration. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. CRC Press: Boca Raton, FL, 1999: 181-214.
7. Bernstein PS, Frederick K, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissue of the human eye. Eye Res 2001; 72: 215-223.
8. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilbutn MD, Mendenez E, Vidal I. Distribution of stereo isomers in the human retina. Exp Eye Res 1997; 64: 211-218.
9. Handelman GJ, Dratz EA, Reay CC, Van Kuijk JG. Carotenoids in the human macula and whole retina. Ophthalmol Vis Sci 1988; 29: 850-855.
10. Beatty S, Henson, D. Macular pigment and age-related macular degeneration. Arch Ophthalmol 1999; 113: 1518-1523.
11. Bernstein PS, Wintch SW. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002; 109(10): 1780-1787.
12. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001; 42(1): 235-240.
13. Seddon J, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT. Dietary carotenoids, vitamins A, C, and E, and advanced age related macular degeneration. JAMA 1994; 272: 1413-1420.
14. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degenration. Arch Ophthalmol 1993; 111: 104-109.
15. Snellen ELM, Verbeek ALM, van den Hoogen GWP. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 2002; 80: 368-371.
16. Vanden Langenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998; 148(2): 204-214.
17. Mares-Perlman JA, Klein R, Klein BE. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996; 114(8): 991-997.
18. Mares-Perlman JA, Fisher AL, Klein R. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2001; 153(5): 424-432.
19. Flood V, Smith W, Wang J, Manzi F, Webb D, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Am Acad Ophthalmol 2002; 109(12) 2272-2277.
20. Mares-Perlman JA, Brady WE, Klein R. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995; 113(12): 1518-1523.
21. Sanders TAB, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and matched control subjects. Am J Clin Nutr 1993; 57: 428.
22. Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Folsom AR. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999; 117(9): 1203-1210.
23. Hammond BR, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997; 38(9): 1795-1801.
24. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Eye Res 1997; 65: 57-62.
25. Berendschot TJM, Goldbohm A, Klopping WAA, Van de Kratts J, Van Norel J, Van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol 2000; 41(11): 3322-3326.
26. Curran-Celentano J, Hammond BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001; 74: 796-802.
27. Broekmans WM, Berendschot TT, Klopping-Ketelaars IA, DeVries AJ, Goldbohm RA, Tijburg LB, Kardinaal AF, Van Poppel G. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 2002; 76(3): 595-603.
28. Hammond BR, Ciulla TA, Snodderly DM. Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 2002; 43(1): 47-50.
29. Johnson EJ, Hammond BR, Yeum KY, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell R. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000; 71: 1555-1562.
30. Hayes KC, Lindsey S, Stephan ZF, Brecker D. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci 1989; 30: 225-232.
31. Goldberg J, Flowerdew J, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration: an analysis of data from the First National Health and Nutrition Examination survey. Am J Epidemiol 1988; 128(4): 700-710.
32. Smith W, Mitchell P, Webb K, Leeder S. Dietary antioxidants and age-related maculopathy. Ophthalmology: the Blue Mountains Eye Study. Ophthalmology 1999; 106(4): 761-767.
33. Simonelli F, Zarrilli F, Mazzeo S, Verde V, Romano N, Savoia M, Testa F, Franco Vitale D, Rinaldi M, Sacchetti L. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clin Chim Acta 2002; 320(1-2): 111-115.
34. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age related macular degeneration? Arch Ophthalmol 1994; 112(2): 222-227.
35. Mares-Perlman JA, Brady WE, Klein R, Klein BEK, Bowen P, Stacewicz-Sapuntazakis M, Palta M. Serum antioxidants and age related macular degeneration in a population-based case control study. Arch Ophthalmol 1995; 113(12): 1518-1523.
36. Dimascio KS, Sies H. Lycopene as the most efficient biologic carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 1: 274.
37. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000; 71: 147-164.
38. Aleman TS, Duncan JL, Bieber ML, DeCastro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome. Invest Ophthalmol Vis Sci 2001; 42(8): 1873-1881.
39. Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, Emmons JM, Bieber ML, Steinberg JD, Bennett J, Stone EM, Macdonald IM, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in choroideremia. Eye Res 2002; 74: 371-381.
40. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology 1992; 99: 546-552.
41. Steinberg EP, Javitt JC, Sharkey PD. The content and cost of cataract surgery. Arch Ophthalmol 1993; 111: 1041-1049.
42. Brown L, Rimm EB, Giovannucci EL, Chasan-Taber L, Seddo JM, Spiegelman D, Willett WC, Hankinson SE. A prospective study of carotenoid intake and risk of cataract extraction in U.S. men. Am J Clin Nutr 1999; 70: 517-524.
43. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE. A prospective study of carotenoid and vitamin A intake and risk of cataract extraction among U.S. women. Am J Clin Nutr 1999; 70: 509-516.
44. Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Greger JL. Dietary antioxidants and incidence of age-related nuclear cataracts. Am J Epidemiol 1999; 149: 810-819.
45. Klein BEK, Klein R, Moss SE. Incident cataract surgery: the Beaver Dam Eye Study. Ophthalmology 1997; 4(4): 573-580.
46. Jacques PF, Chylack LT, Hankinson SE, Khu P, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC, Taylor A. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119(7): 1009-1019.
47. Mares-Perlman JA, Brady WE, Klein BEK, Klein R, Haus GJ, Palta M, Ritter LL, Shoff SM. Diet and nuclear lens opacities. Am J Epidemiol 1995; 141(4): 322-334.
48. Tavani A, Negri E, La Vecchia C. Food and nutrient intake and risk of cataract. Ann Epidemiol 1996; 6(1): 41-46.
49. Berendschot TJM, Broekmans WMR, Klopping-Ketelaars IAA, Kardinaal AFM, Can Poppel G, Van Norren D. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmol 2002; 120: 1732-1737.
50. Hammond BR Jr, Wooten BR, Snodderly DM. Density of the human crystalline lens is related to the macular pigment carotenoid, lutein and zeaxanthin. Optometry Vis Sci 1997; 74(7): 499-504.
51. Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Palta M, Bowen PE, Greger JL. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am J Clin Nutr 1999; 69: 272-277.
52. Gale CR, Hall NF, Phillips DIW, Martyn CN. Plasma antioxidant vitamins and carotenoids and age-related cataract. Am Acad Ophthalmol 2001; 108(11): 1992-1998.
53. Mares-Perlman JA, Brady W, Klein BEK, Klein R, Palta M, Bowen P, Stacewicz-Sapuntzakis M. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest Ophthalmol Vis Sci 1995; 36(2): 276-288.
54. Olmedilla B, Granado F, Blanco I, Herrero C, Vaquero M, Millan I. Serum status of carotenoids and tocopherols in patients with age-related cataracts: a case-control study. J Nutr Health Aging 2002; 6(1): 66-68.
55. Jacques PF, Hartz ST, McGandy RB, Sadowski JA. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am J Clin Nutr 1988; 48: 152-158.
56. Vitale S, West S, Hallfrisch J, Alston C, Wang F, Moorman C, Miller D, Singh V, Taylor HR. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993; 4(3): 195-203.
57. Wong L, Ho SC, Coggon D, Cruddas AM, Hwang CH, Ho CP, Robertshaw AM, MacDonald DM. Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen. J Epidemiol Commun Health 1993; 47: 46-49.
58. Knekt P, Heliovaara M, Rissanen A, Aromaa A, Aaran Ritva-Kaarina. Serum antioxidant vitamins and risk of cataract. BMJ 1992; 305: 1392-1394.
59. Gruber M, Chappell R, Millen AE, Ficek T, Moeller SM, Iannaccone A, Kritchevsky SB, Mares-Perlman JA. Determinants of serum lutein/zeaxanthin in the Third National Health and Nutrition Survey. Am J Epidemiol (in review).
60. Teikari JM, Rautalahti M, Haukka J, Jarvinen P, Hartman AM, Virtamo J, Albanes D, Heinonen O. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. Clinical trial. J Epidemiol Commun Health 1998; 52(7): 468-472.
61. Teikari JM, Virtamo J, Rautalahti M, Palmgren J, Liesto K, Heinonen OP. Long term supplementation with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol Scand 1997; 75(6): 634-640.
62. Christen WG, Manson JE, Glynn RJ, Gaziano M, Sperduto RD, Buring JE, Hennekens CH. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol 2003; 121: 372-378.
63. Age-Related Eye Disease Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no 9. Arch Ophthalmol 2001; 119(10): 1439-1452.
64. Sperduto RD, Hu Tian-Sheng, Milton RC, Zhao Jia-Liang, Everett DF, Cheng Qiu-Fang, Blot WJ, Bing Li, Taylor PR, Jung-Yao Li Dawsey S, Guo, Wan-De. The Linxian Cataract Studies. Arch Ophthalmol 1993; 111: 1246-1252.
65. Chylack LT Jr, Brown NP, Bron A, Hurst M, Kopcke W, Thien U, Schalch W. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophth Epidemiol 2002; 9(1): 49-80.
66. Ford ES, Will JC, Bowman BA, Narayan KM. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999; 149(2): 168-176.
67. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 1998; 105(12): 2264-2270.
68. Davis NP, Morland AB. Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol 2002; 43(1): 281-289.